Immunological Studies with Group B Arthropod-Borne Viruses

IV. Persistence of Yellow Fever Antibodies Following Vaccination with 17D Strain Yellow Fever Vaccine

Edward C. Rosenzweig Department of Microbiology, University of Maryland School of Medicine, Baltimore and the Pan American Sanitary Bureau, Washington, D.C.

Search for other papers by Edward C. Rosenzweig in
Current site
Google Scholar
PubMed Close
,
Robert W. Babione Department of Microbiology, University of Maryland School of Medicine, Baltimore and the Pan American Sanitary Bureau, Washington, D.C.

Search for other papers by Robert W. Babione in
Current site
Google Scholar
PubMed Close
, and
Charles L. Wisseman Jr. Department of Microbiology, University of Maryland School of Medicine, Baltimore and the Pan American Sanitary Bureau, Washington, D.C.

Search for other papers by Charles L. Wisseman Jr. in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.1963.12.230
Volume/Issue:
Volume 12: Issue 2
Page(s):
230–235
Restricted access
Get Permissions

Summary

Neutralizing and hemagglutination-inhibiting antibodies have been found to persist 16 to 19 years following a single dose of 17D strain yellow fever vaccine in retiring Navy and Marine personnel who gave no evidence of other Group B arthropod-borne virus exposure.

Author Notes

Epidemiologist, Pan American Sanitary Bureau, Washington, D. C.

Copyright:
Copyright © 1963, By The American Society of Tropical Medicine and Hygiene 1963
Published Online:
Mar 1963
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Past two years Past Year Past 30 Days
Abstract Views 644 389 3
Full Text Views 19 3 0
PDF Downloads 18 4 0
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save